Clinical trial

The Staged Treatment in Early Psychosis Study

NCT02751632

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-04-01

PhasePHASE3

Study timeline

Study start (actual)2016-04-01Date precision: month

Registry last updated2025-10-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Psychotic Disordersunresolved

Personality Disordersunresolved

Clinical High Riskunresolved

Interventions

Support and Problem Solving TherapyBEHAVIORAL

Cognitive Behavioural Case ManagementBEHAVIORAL

FluoxetineDRUG · verified · RxNorm: fluoxetine

3-monthly monitoringBEHAVIORAL

Sponsors & collaborators

Orygenlead sponsor

National Institute of Mental Health (NIMH)collaborator

University of California, Daviscollaborator

University of California, San Franciscocollaborator

Mapped research locations

MelbourneVictoria, Australia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02751632 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.